Alopecia

Dermatology
2
Pipeline Programs
3
Companies
2
Clinical Trials
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
1
1
Early DiscoveryClinical DevelopmentMarket

On Market (1)

Approved therapies currently available

U
DUTASTERIDEApproved
dutasteride
Unknown Company
oral2016

Competitive Landscape

2 companies ranked by most advanced pipeline stage

GSK
GSKLONDON, United Kingdom
1 program
1
DutasteridePhase 31 trial
Active Trials
NCT02014584Completed117Est. Mar 2016
Lumenis
LumenisAustralia - Chatswood
1 program
1565nm non ablative fractional laserN/A1 trial
Active Trials
NCT04953416Unknown31Est. Mar 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
GSKDutasteride
Lumenis1565nm non ablative fractional laser

Clinical Trials (2)

Total enrollment: 148 patients across 2 trials

NCT02014584GSKDutasteride

Sexual Function in Men Receiving Dutasteride for Androgenetic Alopecia

Start: Jul 2014Est. completion: Mar 2016117 patients
Phase 3Completed
NCT04953416Lumenis1565nm non ablative fractional laser

Fractional Non-ablative Laser for the Treatment of Hair Loss

Start: Sep 2020Est. completion: Mar 202231 patients
N/AUnknown

Related Jobs in Dermatology

MSL/Senior MSL, Dermatology - Tampa, Florida

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

Regional Sales Trainer - Dermatology (Central / West Regions)

AbbVie
Remote
7h ago

Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)

AbbVie
Remote
7h ago

Delegado Especialista Ventas Dermatología (Inmunología)

AbbVie
Remote
11h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
3 companies competing in this space

Related Indications

Dermatitis, Atopic(42)Hidradenitis Suppurativa(30)Chronic Spontaneous Urticaria(21)Alopecia Areata(17)Hidradenitis Suppurativa (HS)(10)Vitiligo(9)Rosacea(6)Chronic Urticaria(5)Pruritus(5)Androgenetic Alopecia(5)